48
Views
5
CrossRef citations to date
0
Altmetric
Clinical Trial Report

The GetGoal clinical trial program of lixisenatide, a once-daily GLP-1 receptor agonist

, &
Pages 513-525 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alan J Garber. (2012) Novel GLP-1 receptor agonists for diabetes. Expert Opinion on Investigational Drugs 21:1, pages 45-57.
Read now

Articles from other publishers (4)

Dilip Sharma, Suril Verma, Shivani Vaidya, Kiran Kalia & Vinod Tiwari. (2018) Recent updates on GLP-1 agonists: Current advancements & challenges. Biomedicine & Pharmacotherapy 108, pages 952-962.
Crossref
Justin J. Wilkins, Michel Dubar, Bernard Sébastien & Christian Laveille. (2014) A drug and disease model for lixisenatide, a GLP-1 receptor agonist in type 2 diabetes. The Journal of Clinical Pharmacology 54:3, pages 267-278.
Crossref
Shelley Elkinson & Gillian M. Keating. (2013) Lixisenatide: First Global Approval. Drugs 73:4, pages 383-391.
Crossref
Hyun-Ji ChunHyuk-Sang Kwon. (2013) Clinical Efficacy of Glucagon Like Peptide-1 (GLP-1) Analogues. The Journal of Korean Diabetes 14:3, pages 125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.